{"preliminary_commentary":{"by_channel":{"x_thread":20},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT06205485\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's free public preview; the full report is still bought."},"commentary_summary":null,"drugs_tested":[["FOLFOX"],["CAPOX"]],"indication":"early rectal cancer","name":"NEO-RT","nct_id":"NCT06205485","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=neo-rt-nct06205485. The price is an estimate of verified statements from the commentary indexed so far. Final coverage is set when the report is built. You never pay more than quoted: if the report is delivered at a smaller size, you pay that size's price, and anything paid above it is refunded. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_rule":"Never more than quoted: the buyer pays the smaller of price_usd and the price the delivered edition is sold at.","price_usd":1250,"size":"standard","size_rule":"Standard: 151–300 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":"NEO-RT","arms":[{"description":"FOLFOX= Six cycles of modified FOLFOX consisting of leucovorin, oxaliplatin and bolus fluoruracil (optional), infusional fluorouracil.\n\nCAPOX= Capecitabine twice daily for 14 days and Oxaliplatin on day 1","label":"FOLFOX OR CAPOX","type":"ACTIVE_COMPARATOR"},{"description":"Standard dose of infusional 5-Fluorouracil/capecitabine and radiation","label":"ChemoRT","type":"ACTIVE_COMPARATOR"}],"collaborators":["Alliance for Clinical Trials in Oncology","ECOG-ACRIN Cancer Research Group","NRG Oncology","SWOG Cancer Research Network"],"completion_date":{"date":"2030-06-30","type":"ESTIMATED"},"conditions":["Rectal Cancer"],"enrollment":{"count":250,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"Leucovorin","otherNames":[],"type":"DRUG"},{"name":"Oxaliplatin","otherNames":[],"type":"DRUG"},{"name":"Fluoruracil","otherNames":[],"type":"DRUG"},{"name":"Capecitabine","otherNames":[],"type":"DRUG"},{"name":"Radiation","otherNames":[],"type":"RADIATION"}],"last_update":"2026-07-14","lead_sponsor":"Canadian Cancer Trials Group","official_title":"A Phase 3 Randomized Trial Of Neoadjuvant Chemotherapy, Excision And Observation Versus Chemoradiotherapy For Early Rectal Cancer","overall_status":"RECRUITING","phases":["PHASE3"],"primary_completion_date":{"date":"2030-01-30","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Clinical response rate upon re-staging","timeFrame":"6 years"},{"measure":"Quality of Life defined using the LARS score","timeFrame":"6 years"}],"references":[],"start_date":{"date":"2024-06-26","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer","url":"https://clinicaltrials.gov/study/NCT06205485"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.2","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/neo-rt-nct06205485"}